Aerin Medical Inc.
“LASIK for the nose” to improve nasal breathing
This article was originally published in Start Up
Executive Summary
Aerin Medical Inc.’s new procedure, called InFlux, could replace an invasive surgery with a 15-minute in-office procedure to help patients who complain of poor nasal breathing, and also serve people who simply want to breathe better.
You may also be interested in...
ENT Devices: Large Markets, Minimally Invasive Procedures Fuel Innovation
For innovators in the medical device industry, the otolaryngology or ENT (ear, nose, and throat) specialty offers just about everything that investors look for these days. Profiles of Aerin Medical, Spirox, Fiagon AG Medical, and ENTvantage Diagnostics.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.